Sanara MedTech Inc. SMTI Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost at other companies
Other financials
Where this comes from
Reported directly by Sanara MedTech Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost.
The official record: Sanara MedTech Inc.’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sanara MedTech Inc.'s deferred tax assets, tax deferred expense, compensation and benefits, share-based compensation cost.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sanara MedTech Inc.'s deferred tax assets, tax deferred expense, compensation and benefits, share-based compensation cost?
- Sanara MedTech Inc. (SMTI) reported deferred tax assets, tax deferred expense, compensation and benefits, share-based compensation cost of $509.03K in Q4 2025.
- What is the long-term trend for Sanara MedTech Inc.'s deferred tax assets, tax deferred expense, compensation and benefits, share-based compensation cost?
- Over 3 years (2022 to 2025), Sanara MedTech Inc.'s deferred tax assets, tax deferred expense, compensation and benefits, share-based compensation cost has grown at a 29.9% compound annual growth rate (CAGR), from $232.25K to $509.03K.